ONCOTRACKER INC has a total of 15 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, environmental technology and biotechnology are WANG YUWAN, LERENTANG PHARMACEUTICAL FACTORY OF TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CO LTD and CENTRE FOR DIGESTIVE DISEASES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Philippines | 1 | |
#11 | Singapore | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Peptides | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Berenson James Richard | 11 |
#2 | James Richard Berenson | 2 |
#3 | Chen Haiming | 1 |
#4 | Berenson James R | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020092792A2 | Method of enhancing immune-based therapy | |
US2020030343A1 | Anti-cancer effects of jak2 inhibitors in combination with thalidomide derivatives and glucocorticoids | |
US2020264184A1 | Diagnostic, prognostic, and monitoring methods for solid tumor cancers | |
CN108025001A | For treating the gamma secretase modulators of immune system dysfunction |